Manufacture of medicines producer price index growth rate (monthly) vs Oncology novel active substance (NAS) launches (cumulative) in China

Manufacture of medicines producer price index growth rate (monthly) and Oncology novel active substance (NAS) launches (cumulative) in China, compared over time.

Change the pair

Compare different indicators

The series

Over time

China, spaced by time . Different units, drawn on separate scales and clipped to the years both series publish — earlier history stays on each indicator's own page. Read the values, not the heights.

Manufacture of medicines producer price index growth rate (monthly)

Unit: % · 2 observations

Line chart
Manufacture of medicines producer price index growth rate (monthly)Manufacture of medicines producer price index growth rate (monthly). 2 observations from as of 31 Aug 2026 to August 2026, ranging from -4.4% to -0.2%. Latest value -0.2% (August 2026). % -5 -4 -3 -2 -1 0 2015 2017 2019 2021 2023 2025 -4.4% -0.2%
Manufacture of medicines producer price index growth rate (monthly)Manufacture of medicines producer price index growth rate (monthly). 2 observations from as of 31 Aug 2026 to August 2026, ranging from -4.4% to -0.2%. Latest value -0.2% (August 2026). % -5 -4 -3 -2 -1 0 2015 2017 2019 2021 2023 2025 -4.4% -0.2%
Manufacture of medicines producer price index growth rate (monthly)Manufacture of medicines producer price index growth rate (monthly). 2 observations from as of 31 Aug 2026 to August 2026, ranging from -4.4% to -0.2%. Latest value -0.2% (August 2026). % -5 -4 -3 -2 -1 0 2015 2017 2019 2021 2023 2025 -4.4% -0.2%
View the underlying data
Manufacture of medicines producer price index growth rate (monthly)
Period Type Value
as of 31 Aug 2026 Actual -4.4%
August 2026 Actual -0.2%
Source: NBS China · CC BY 4.0 · Full series

Oncology novel active substance (NAS) launches (cumulative)

Unit: count · 2 observations

Line chart
Oncology novel active substance (NAS) launches (cumulative)Oncology novel active substance (NAS) launches (cumulative). 2 observations from 2015–2019 to 2020–2024, ranging from 37 to 84. Latest value 84 (2020–2024). 0 20 40 60 80 100 2015 2017 2019 2021 2023 2025 37 84
Oncology novel active substance (NAS) launches (cumulative)Oncology novel active substance (NAS) launches (cumulative). 2 observations from 2015–2019 to 2020–2024, ranging from 37 to 84. Latest value 84 (2020–2024). 0 30 60 90 2015 2017 2019 2021 2023 2025 37 84
Oncology novel active substance (NAS) launches (cumulative)Oncology novel active substance (NAS) launches (cumulative). 2 observations from 2015–2019 to 2020–2024, ranging from 37 to 84. Latest value 84 (2020–2024). 0 30 60 90 2015 2017 2019 2021 2023 2025 37 84
View the underlying data
Oncology novel active substance (NAS) launches (cumulative)
Period Type Value
2015–2019 Actual 37
2020–2024 Actual 84
Source: IQVIA · CC BY 4.0 · Full series

Provenance

Where these numbers come from

Manufacture of medicines producer price index growth rate (monthly)

Month-on-month percentage change in producer prices for the manufacture of medicines (pharmaceuticals) industry.

2 observations in China · source organisations: NBS China

Oncology novel active substance (NAS) launches (cumulative)

Total number of oncology novel active substances launched over a stated multi-year period.

2 observations in China · source organisations: IQVIA

Data published under CC BY 4.0. Series A as JSON · Series B as JSON

Keep exploring

Related